Expert Review of Pharmacoeconomics & Outcomes Research, Volume 17, Issue 3 (2017)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Pharmacoeconomics & Outcomes Research, Volume 17, Issue 3 (2017)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Volume 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
Recent amendments to NICE’s value-based assessment of health technologies: implicitly inequitable?
Mike Paulden
Pages: 239-242
Published online: 23 May 2017
First Page PreviewforRecent amendments to NICE’s value-based assessment of health technologies: implicitly inequitable? | Full Text | References | PDF (566.4 KB)
  • 13235 Views
  • 55 CrossRef citations
  • 0Altmetric
Free Access

Special Report

Article
Epidermal growth factor inhibitors in first-line for metastatic colorectal cancer with ras wild-type: a perspective based on pharmacological costs
Jacopo Giuliani & Andrea Bonetti
Pages: 243-248
Published online: 03 Jul 2017
AbstractforEpidermal growth factor inhibitors in first-line for metastatic colorectal cancer with ras wild-type: a perspective based on pharmacological costs | Full Text | References | PDF (498.8 KB)
  • 98 Views
  • 1 CrossRef citations
  • 0Altmetric

Review

Review
A systematic review of the health economic consequences of quadrivalent influenza vaccination
Pieter T. de Boer, Britt M. van Maanen, Oliver Damm, Bernhard Ultsch, Franklin C.K. Dolk, Pascal Crépey, Richard Pitman, Jan C. Wilschut & Maarten J. Postma
Pages: 249-265
Published online: 28 Jun 2017
AbstractforA systematic review of the health economic consequences of quadrivalent influenza vaccination | Full Text | References | PDF (1.8 MB) | Supplemental
  • 4773 Views
  • 41 CrossRef citations
  • 0Altmetric
Open Access
Review
Micro factors bringing the pharmaceutical industry to a seismic shaking a qualitative research
Raphaela Marie Louisa Dierks, Olivier Bruyère & Jean-Yves Reginster
Pages: 267-274
Published online: 14 Jul 2017
AbstractforMicro factors bringing the pharmaceutical industry to a seismic shaking a qualitative research | Full Text | References | PDF (644.2 KB)
  • 187 Views
  • 1 CrossRef citations
  • 0Altmetric
Review
Critical exploration of co-occurring Attention-Deficit/Hyperactivity Disorder, mood disorder and Substance Use Disorder
Judith Regnart, Ilse Truter & Anneke Meyer
Pages: 275-282
Published online: 13 Jul 2017
AbstractforCritical exploration of co-occurring Attention-Deficit/Hyperactivity Disorder, mood disorder and Substance Use Disorder | Full Text | References | PDF (899.5 KB)
  • 429 Views
  • 15 CrossRef citations
  • 0Altmetric

Original Research

Article
A conceptual framework for a long-term economic model for the treatment of attention-deficit/hyperactivity disorder
Balázs Nagy, Juliana Setyawan, David Coghill, Tamás Soroncz-Szabó, Zoltán Kaló & Jalpa A. Doshi
Pages: 283-292
Published online: 26 Dec 2016
AbstractforA conceptual framework for a long-term economic model for the treatment of attention-deficit/hyperactivity disorder | Full Text | References | PDF (1.1 MB) | Supplemental
  • 192 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland
Erkki Soini, Taru Hallinen, Mélanie Brignone, Rosanne Campbell, Françoise Diamand, Sandrine Cure, Maria Aalto-Setälä, Natalya Danchenko, Hannu Koponen & Katarzyna Kolasa
Pages: 293-302
Published online: 21 Oct 2016
AbstractforCost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland | Full Text | References | PDF (902 KB)
  • 773 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
The impact of comorbidities on costs, utilities and health-related quality of life among HIV patients in a clinical setting in Bogotá
Mark JM Van Duin, Rafael Conde, Ben Wijnen, Silvia MAA Evers, Javier L Gonzalez-Rodriguez, Mark JG Govers & Mickaël Hiligsmann
Pages: 303-310
Published online: 25 Oct 2016
AbstractforThe impact of comorbidities on costs, utilities and health-related quality of life among HIV patients in a clinical setting in Bogotá | Full Text | References | PDF (1.1 MB)
  • 1618 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access
Article
Impacts of regulated competition on pricing in Chinese pharmaceutical market under urban employee basic medical insurance
Mingyue Zhao & Jing Wu
Pages: 311-320
Published online: 08 Nov 2016
AbstractforImpacts of regulated competition on pricing in Chinese pharmaceutical market under urban employee basic medical insurance | Full Text | References | PDF (865.5 KB)
  • 394 Views
  • 5 CrossRef citations
  • 0Altmetric

Explore articles